CLASS:
NR547: Differential Diagnosis in Psychiatric-Mental Health across the Lifespan Practicum
Preparing the Assignment
Follow these guidelines when completing each component of the assignment. Contact your course faculty if you have questions.
Please read the following please note that references to DSM 5 are accurate as anxiety content was not updated in the DSM 5 TR (APA, 2023).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573566/Links to an external site.
https://cdn.neiglobal.com/content/congress/2020/pdf-slides/C02-anxiety-syl.pdfLinks to an external site..
Answer the questions below after reviewing the full presentation.
Download the PowerPoint slidesLinks to an external site. and listen to the audio presentationLinks to an external site..
Answer the questions below after reviewing the full presentation.
Initial Post
Treatment of anxiety can be complex. Psychiatric mental health nurse practitioners (PMHNPs) may provide care to clients with treatment-refractory anxiety.
Define treatment refractory anxiety.
Describe two common comorbidities of treatment refractory anxiety.
Discuss two possible approaches to treatment for treatment refractory anxiety.
Identify the most appropriate response to a client who states that they use marijuana to manage their anxiety. Discuss the education the PMHNP should provide.
Identify the most appropriate response to a client who states that they use Silexan to manage their anxiety. Discuss the education the PMHNP should provide?
SOLUTION
Treatment-refractory anxiety is characterized by anxiety disorders that do not respond or exhibit only a poor response to at least two levels of treatment, medication (SSRIs, SNRIs, benzodiazepines) or/and psychotherapy (CBT, exposure therapy). These treatments must have been given at accurate dosages and duration and yes affirmative client conformity should have been established. Clients with treatment-refractory anxiety often experience persistent and debilitating symptoms that significantly impair their daily functioning, work, relationships, and overall quality of life.
Contributing factors to treatment-refractory anxiety may include:
Genetic predisposition impacting medication metabolism or treatment response.
Chronic stress and environmental triggers that perpetuate
.
